Department of Vascular Surgery and Intervention, The Affiliated Suzhou Hospital of Nanjing Medical University, Suzhou Municipal Hospital, 188 Guangji Road, Gusu District, Suzhou, 215000, Jiangsu, China.
Mol Biotechnol. 2023 Oct;65(10):1664-1678. doi: 10.1007/s12033-023-00676-4. Epub 2023 Feb 4.
Endothelial progenitor cells (EPCs) contribute to recanalization of deep vein thrombosis (DVT). MicroRNAs (miRNAs) play regulatory roles in functions of EPCs, which is becoming a promising therapeutic choice for thrombus resolution. The main purpose of this study was to explore the effect of miR-125a-5p on EPC functions in deep vein thrombosis (DVT). EPCs were isolated from the peripheral blood of patients with DVT. In DVT mouse models, DVT was induced by stenosis of the inferior vena cava (IVC). The levels of miR-125a-5p and myeloid cell leukemia sequence 1 (MCL-1) in EPCs and thrombi of DVT mice were detected by RT-qPCR. EPC migration, angiogenesis, and apoptosis were estimated by Transwell assay, tube formation assay, and flow cytometry analysis. Luciferase reporter assay was utilized for detecting the binding of miR-125a-5p and MCL-1. The phosphorylation of PI3K and AKT was estimated by western blot. DVT formation in vivo was observed through hematoxylin-eosin (H&E) staining. The expression of thrombus resolution marker, CD34 molecule (CD34), in the thrombi was measured by immunofluorescence staining. MiR-125a-5p upregulation repressed EPC migration and angiogenesis and facilitated apoptosis. MiR-125a-5p downregulation showed the opposite effect. MCL-1 was targeted and negatively regulated by miR-125a-5p. Additionally, miR-125a-5p inhibited the PI3K/AKT pathway in EPCs. Inhibition of MCL-1 or PI3K/AKT pathway reversed the effect of miR-125a-5p knockdown on EPC functions. The in vivo experiments revealed that miR-125a-5p downregulation repressed thrombus formation and promoted the homing capability of EPCs to the thrombosis site, thereby alleviating DVT mice. Downregulation of miR-125a-5p promotes EPC migration and angiogenesis by upregulating MCL-1, thereby enhancing EPC homing to thrombi and facilitating thrombus resolution.
内皮祖细胞(EPCs)有助于深静脉血栓形成(DVT)的再通。微小 RNA(miRNAs)在 EPCs 的功能中发挥调节作用,这成为血栓溶解的一种有前途的治疗选择。本研究的主要目的是探讨 miR-125a-5p 对深静脉血栓形成(DVT)中 EPC 功能的影响。EPCs 从 DVT 患者的外周血中分离出来。在 DVT 小鼠模型中,通过下腔静脉(IVC)狭窄诱导 DVT。通过 RT-qPCR 检测 EPCs 和 DVT 小鼠血栓中 miR-125a-5p 和髓样细胞白血病序列 1(MCL-1)的水平。通过 Transwell 测定、管形成测定和流式细胞术分析评估 EPC 迁移、血管生成和细胞凋亡。荧光素酶报告测定用于检测 miR-125a-5p 和 MCL-1 的结合。通过 Western blot 测定 PI3K 和 AKT 的磷酸化。通过苏木精-伊红(H&E)染色观察体内 DVT 的形成。通过免疫荧光染色测量血栓中血栓溶解标志物 CD34 分子(CD34)的表达。miR-125a-5p 的上调抑制 EPC 迁移和血管生成并促进细胞凋亡。miR-125a-5p 的下调则显示出相反的效果。MCL-1 是 miR-125a-5p 的靶标并受其负调控。此外,miR-125a-5p 抑制 EPC 中的 PI3K/AKT 通路。EPC 中 MCL-1 或 PI3K/AKT 通路的抑制逆转了 miR-125a-5p 敲低对 EPC 功能的影响。体内实验表明,miR-125a-5p 的下调抑制血栓形成并促进 EPC 向血栓部位归巢,从而缓解 DVT 小鼠。miR-125a-5p 的下调通过上调 MCL-1 促进 EPC 迁移和血管生成,从而增强 EPC 向血栓的归巢并促进血栓溶解。